/>

Pages

Wednesday, November 21, 2018

NEWS 21 NOV 2018

NEWS FROM USA

NDA Approvals        

Approval Date

Drug

NDA Sponsor

Brand Name

Prescribing information

16 Nov 2018

Rifamycin Dr Tablets

Cosmo Technologies 

Aemcolo

Label

20 Nov 2018

Emapalumab-Lzsg Injection

Novimmune 

Gamifant

Link

 

ANDA Approvals 

 

Approval Date

Drug Product

ANDA

Sponsor

Corresponding RLD

Number Of Other Approved Generics

19 Nov 2018

Docosanol Cream

Actavis 

Abreva (GSk)

None

20 Nov 2018

Vardenafil Hydrochloride ODT

Alembic

Staxyn (Bayer)

First approval for ODT

20 Nov 2018

Hydrocodone And Acetaminophen Tablets

Elite Pharma

Narco

Four

*Highlighted products are the 1st generics approval for the corresponding RLD

 

Tentative ANDA Approvals

 

Approval Date

Drug

Company

16 Nov 2018

Deferasirox

Zydus

19 Nov 2018

Pregabalin

Rising

 


 

NEW GENERICS LAUNCHES IN US

DRUG

COMPANY

Corresponding RLD

Annual sales quoted in press release as per IQVIA

Press Release

Tetrabenazine Tablets

Lupin

Xenazine (Valeant Pharmaceuticals)

$153 Million

Link

                                                                                                                                               

OTHER NEWS FROM THE USA

Dr. Reddy's Laboratories announces favorable outcome in Buprenorphine and Naloxone (Suboxone) Sublingual Film patent litigation                                                                                                                 

 

                                                                            

Now, you can also follow us on twitter @pharmacaptions. If you have any query/suggestion then please write us at pharmacaption@gmail.com

                                                                                                                     

 

 

 

 

                                                                

No comments:

Post a Comment